The skin beneath the eyes is the thinnest and most structurally complex tissue on the face. When volume loss, ligament changes, and fat redistribution converge in this zone, the result is a hollowed, shadowed appearance that reads as fatigue regardless of how rested you actually are. Dermal fillers under the eyes — specifically hyaluronic acid (HA) injected into the tear trough — are among the most requested non-surgical treatments in aesthetic medicine, and for good reason. Performed on the right patient with the right technique, they produce a quietly remarkable transformation. But this is also one of the highest-stakes injection sites on the face, and a transparent understanding of why matters as much as the result itself.
The Anatomy of the Under-Eye Area: Tear Trough and Periorbital Structures
The tear trough is not simply a crease or a wrinkle. It is a multidimensional anatomical depression shaped by the interaction of bone, ligament, muscle, and fat — and understanding each layer is what separates a precise, safe injection from a problematic one.
The layered architecture of the tear trough begins at the skin surface and descends through subcutaneous tissue, the orbicularis oculi muscle, and the periosteal membrane overlying the maxillary bone. Anatomic studies confirm that the tear trough region contains skin, subcutaneous tissue, orbicularis oculi muscle, and periosteal membrane — and notably, there is no subcutaneous fat above the tear trough itself, while the malar fat pad exists below it. This absence of a cushioning fat layer above the groove is one reason the area looks hollow and why injected product can be so easily seen if placed incorrectly.
The orbicularis retaining ligament (ORL) is the primary structural architect of the tear trough groove. Cadaveric research has demonstrated that the ORL is a true circumferential periorbital ligament, arising from the orbital rim and inserting into both the orbicularis muscle and the overlying skin — acting as a tether that creates a visible demarcation between the lower eyelid and cheek. Medially, this structure is often described as the tear trough ligament proper. The tear trough ligament is an osteocutaneous ligament that runs between the palpebral and orbital parts of the orbicularis oculi muscle.
How aging reshapes this anatomy is a cascading process. Tear trough deformity is most commonly the result of a multifactorial process: age-related fat atrophy, ligamentous weakening with resultant inferior displacement of the infraorbital fat, and maxillary bone resorption often result in a tear trough deformity. Simultaneously, the attenuation of the orbital septum leads to anterior pseudoherniation of the intraorbital fat pads, creating the typical bulging of the lower eyelid, while age-related resorption of the sub-orbicularis oculi fat (SOOF) and deep medial cheek fat, combined with descent of the malar fat pad, contributes to the formation of the tear trough deformity and mid-cheek groove.
The periorbital region presents unique anatomical challenges: under-eye skin measures just 0.5mm thick, the thinnest on the entire body and roughly four times thinner than cheek skin, providing little camouflage for improperly placed filler. The combination of thin skin and minimal subcutaneous fat creates high translucency, making anything beneath the surface — blood vessels, pigmentation, or misplaced filler — immediately visible. This is precisely why anatomical knowledge is non-negotiable in this treatment zone.
Who Is a Good Candidate for Under-Eye Fillers
The ideal candidate for dermal fillers under the eyes has true volumetric hollowing, good skin elasticity, and no structural conditions that filler cannot address. Getting this assessment right is the foundation of a successful outcome.
The best candidates for under-eye filler are patients who have true hollows or depressions under the eye and relatively good skin quality and tightness in the area. When a patient has an actual depression under the eye and good skin quality, it is straightforward to fill the area and for the skin to maintain the filler in place.
From a clinical perspective, good candidacy typically includes several converging factors. The hollowing should be primarily volumetric in origin — driven by fat atrophy and bony resorption — rather than by excess skin or herniated fat. Skin should retain reasonable elasticity; the snap-back test at the lower lid margin gives a useful indication. Due to the central role of the eyes in communication and perceptions of age and beauty and the predictable patterns of aging in this area (including skin laxity, reduced volume, and changes in the retaining ligaments and skeletal structures), this area is often the target of facial rejuvenation.
Many of our patients at FAH Signature Clinique who enquire about dermal fillers under the eyes fall into two groups: Prevention-Minded Professionals in their early 30s to 40s who are told they look tired despite adequate sleep, and Restorative Seekers in their 40s to 60s who have noticed progressive hollowing over recent years. Both groups can be excellent candidates — though the clinical picture varies significantly between them, and each assessment must address the individual anatomy rather than the age on the chart.
Who Should Avoid Under-Eye Fillers
Honest patient selection is what separates a consistently excellent injector from one who simply says yes to every consultation. Several conditions make dermal fillers under the eyes inappropriate, and identifying them protects both patient safety and the clinical outcome.
| Condition | Why Filler Is Problematic | Better Alternatives |
|---|---|---|
| Significant fat pad herniation (“true bags”) | Filler will more likely exacerbate the bags than improve them. It is very difficult to inject enough filler around the bags to make them appear even, and more puffiness is created rather than camouflage. | Lower blepharoplasty, surgical fat repositioning |
| Excess skin laxity | If a patient has too much skin laxity in the area, filler can unfortunately end up looking lumpy. | Radiofrequency skin tightening, surgical blepharoplasty |
| Malar edema / festoons | Because of the hydrophilic nature of HA fillers, individuals with significant malar edema, festoons, or fluid retention conditions may experience worsened puffiness following HA filler, as the filler can draw more fluid into the area. | Address underlying cause first; biostimulators, lymphatic therapies |
| Pigmentation-driven dark circles | Fat pad herniation, skin laxity, and darkly pigmented skin under the eyes will not be improved by tear trough filler. | Topical brighteners (arbutin, retinol), laser treatments, PRP |
| Active skin infection or inflammation in the zone | Risk of spreading infection; filler acts as a foreign body in an infected field. | Treat infection first, defer filler |
| Autoimmune conditions or bleeding disorders | An extensive medical history is conducted to exclude bleeding disorders, autoimmune diseases, or active infections. | Individual medical assessment required |
| Chronic malar edema from systemic causes | Contraindications include chronic edema, poor skin tone, festoons, and malar bags. A detailed history of systemic conditions like thyroid dysfunction and medications affecting fluid balance is essential. | Address systemic cause; consider alternative volume strategies |
A consultation is not a formality — it is the clinical event that determines whether filler is the right tool for a given face. When it is not, saying so clearly is the most expert thing a practitioner can do.
The Tyndall Effect and Other Risks to Know
The Tyndall effect is the most discussed complication in periorbital filler and, crucially, one of the most preventable. Understanding what causes it — and how it differs from other post-treatment changes — helps patients make informed decisions and recognize early warning signs.
What Is the Tyndall Effect?
The Tyndall effect is an optical phenomenon that occurs when a hyaluronic acid-based filler is injected too superficially into the thin skin of the under-eye area. When light passes through the skin and strikes the gel particles, it scatters, creating an unsightly bluish or grayish discoloration similar to a persistent bruise. The physics behind it are straightforward: blue light has a shorter wavelength than red light, and scatters approximately 10 times more when passing through small particles. The result is a tint beneath the skin that cannot be covered with concealer and does not fade on its own.
While a bruise is caused by a small blood leak and fades within a few days, changing color from purple to yellow-green, the Tyndall effect does not resolve spontaneously and may persist for months. This distinction matters clinically: patients and practitioners who mistake a Tyndall presentation for ordinary bruising may delay appropriate treatment.
How It Is Prevented
Prevention rests on two pillars: correct injection depth and appropriate product selection. While a Tyndall reaction can occur in the best of hands, it is minimized by appropriate placement of the filler around the eyes — meaning deeper placement in small amounts. Supraperiosteal placement, directly above the bone, keeps the product well beneath the thin dermal layers that would render it visible. Not all hyaluronic acid fillers are appropriate for the tear trough. Products designed for deep volume replacement or structural support are far too viscous for the delicate under-eye area, and using the wrong product, even with correct technique, increases Tyndall effect risk.
How It Is Corrected
Hyaluronidase is the gold-standard solution for correcting the Tyndall effect caused by HA fillers. This enzyme breaks down hyaluronic acid, effectively dissolving the filler and allowing the body to metabolise it naturally. The treatment is highly effective, with results often visible within 24 hours, and in many cases the blue tint begins to fade almost immediately after the enzyme is administered. This reversibility is one of the genuine advantages of hyaluronic acid over permanent or semi-permanent fillers in this anatomically sensitive zone.
Other Periorbital Risks
Beyond the Tyndall effect, the periorbital region carries additional risks that any informed patient should understand. There are risks such as edema (swelling) and vascular occlusion (blocking of blood vessels), which are particularly concerning given the sensitive nature of the eye area. Vascular compromise in this zone is rare but serious, given the proximity of the infraorbital vessels and the angular artery. Nodule formation and filler migration are also possible, particularly when excessive volumes are used or when the product is not well-suited to the tissue plane. Choosing an injector with advanced periorbital anatomy training is the single most important risk-mitigation measure a patient can take.
What the Treatment Involves and What to Expect
A well-executed tear trough filler appointment is a measured, precise procedure — not a quick injection. From consultation through to the days following treatment, knowing what each stage involves helps set accurate expectations and reduces post-treatment anxiety.
The Consultation
The consultation is where the real clinical work begins. Your injector should assess the full periorbital anatomy, including the depth and extent of the hollowing, the quality and laxity of your lower eyelid skin, the presence or absence of fat pad herniation, and any tendency toward malar edema. Medical history — including medications that affect platelet function, any history of autoimmune conditions, and prior injectable treatments in the area — is reviewed in full. Proper diagnosis, understanding of anatomical variations, and accurate injection techniques are essential to avoid complications and achieve natural, aesthetically pleasing outcomes. Treatments should consider the patient’s unique anatomy and potential adjunctive procedures to ensure balanced and harmonious facial rejuvenation.
The Procedure
Under-eye filler appointments are typically brief, often completed in 30 to 45 minutes from start to finish. Your provider will apply a topical numbing cream to the area first, then carefully inject small amounts of filler using a fine needle or cannula. You may feel mild pressure or a slight pinching sensation during the injections, and most patients find the experience very tolerable.
The choice of needle versus cannula is a nuanced clinical decision. The cannula technique uses a thin, flexible tube with a blunt tip rather than a sharp needle. The blunt tip slides softly under the skin, avoids puncturing tissue and blood vessels, and enables more accurate filler application under the eyes. That said, some experienced injectors prefer a fine-gauge needle for its precision in targeting specific anatomical planes, particularly in cases where the depression is narrow and medial. The technique is tailored to the individual anatomy, not applied universally.
Injection depth targeting the supraperiosteal plane — just above the periosteum — provides optimal structural support while keeping the product well away from the superficial tissue planes that cause visible complications. During filler injections to correct this area, it is advisable to inject below the ligament and push upwards, creating a lifting effect. Volumes used are conservative: small, precise deposits rather than large boluses. Less is consistently more in the periorbital zone.
Immediately After Treatment
Immediately after treatment, you may notice some swelling, mild bruising, or tenderness. This is completely normal and typically resolves within a few days to a week. Results are often visible right away, though final results become clearer once any initial swelling settles, usually within one to two weeks. Patients are typically advised to avoid blood-thinning supplements, alcohol, and intense physical exercise for several days before and after treatment to minimize bruising risk.
Our approach at FAH Signature Clinique always includes a follow-up review at the two-week mark, when swelling has fully resolved and the filler has integrated into the tissue. This appointment is where the final result is assessed and any minor refinements are discussed — it is a standard part of the process, not an afterthought.
Realistic Results and Limitations of Under-Eye Filler
Dermal fillers under the eyes, when performed on the right candidate, produce a refreshed, rested appearance that reads as natural rather than treated. But clarity about what filler can and cannot achieve prevents disappointment and builds lasting trust.
What You Can Realistically Expect
For patients with true volumetric hollowing, well-executed filler softens the shadow cast by the depression, smooths the lid-cheek junction, and reduces the “tired” appearance that persists regardless of sleep. The change is additive to what you already have, not a replacement of it. Under-eye filler results are visible immediately after treatment, with optimal results appearing within 2 to 4 weeks once swelling subsides. HA-based under-eye fillers generally last between 9 and 18 months. Some patients find the lower end of that range is typical for them; others maintain results closer to 18 months, particularly when the upper cheeks are treated simultaneously to provide enhanced volumetric support.
The goal of treatment is a refreshed version of your own face — not a dramatically different one. Each face has a unique anatomy, and the filler plan is designed to work with your specific proportions, not impose a template on them. This is the approach Fahimeh takes in every consultation: reading what the face needs and calibrating treatment to restore balance, not to override it.
What Filler Cannot Do
It is equally important to be clear about the limitations. Filler cannot improve pigmentation-driven dark circles, tighten loose lower eyelid skin, or eliminate true fat pad herniation. Attempting to mask herniated fat pads with increasing volumes of filler typically worsens the appearance over time, amplifying puffiness rather than correcting it. Skin texture, fine crepiness, and deep dermal laxity are better addressed with complementary treatments such as radiofrequency, microneedling, or mesotherapy to improve skin quality in the periorbital zone.
For patients who have had previous filler placed elsewhere and are considering the tear trough, a full assessment of existing product is part of the pre-treatment review. Layering new filler on top of residual product from prior treatments can compound puffiness and complicate the outcome. When prior filler is present, dissolution with hyaluronidase before re-treatment is often the most responsible starting point.
For a deeper look at how our clinic approaches volume restoration and collagen stimulation across the face, including biostimulatory options that complement tear trough work, see our overview of Sculptra and poly-L-lactic acid treatments.
Is Under-Eye Filler Right for You?
Dermal fillers under the eyes represent one of the most clinically rewarding procedures in non-surgical aesthetic medicine — and one of the most unforgiving when performed without rigorous anatomical grounding and honest patient selection. The periorbital anatomy is layered, ligament-driven, and unforgiving of imprecision. The right product, at the right depth, in the right patient, produces results that are quietly transformative. The wrong combination produces the exact outcome most patients fear: a treated, unnatural look that undermines confidence rather than restoring it.
If you are considering this treatment, the most important first step is an honest, thorough consultation with an injector who will assess your specific anatomy, discuss the full picture of what filler can and cannot achieve for your face, and decline to proceed if another approach would serve you better.
FAH Signature Clinique offers personalized tear trough consultations at our Nun’s Island clinic in Montreal. Whether you are in the early stages of research or ready to discuss a treatment plan, we welcome the conversation. Book a consultation with Fahimeh to explore whether dermal fillers under the eyes are the right next step for your goals.
Frequently Asked Questions
How long do dermal fillers under the eyes last?
Hyaluronic acid fillers in the tear trough area typically last between 9 and 18 months, depending on the product used, your metabolism, and your injector’s technique. Because the under-eye area is relatively low-movement, some patients retain results at the longer end of that range. Periodic touch-up appointments help maintain continuity.
Will under-eye filler get rid of my dark circles?
It depends on what is causing your dark circles. Filler works well when darkness is caused by shadowing from a hollow or depression. If the darkness is due to pigmentation in the skin itself, filler will not improve it and other treatments such as topical brighteners or laser may be more appropriate. A thorough consultation helps distinguish between the two causes.
What is the Tyndall effect and can it be fixed?
The Tyndall effect is a bluish or grayish discoloration that appears when hyaluronic acid filler is placed too superficially under the thin skin of the under-eye area. Light scatters off the gel particles and creates the characteristic tint. It does not resolve on its own like a bruise does, but it can be effectively corrected by injecting hyaluronidase, an enzyme that dissolves hyaluronic acid. Prevention through correct injection depth and product selection is always preferred.
Am I a good candidate for tear trough filler?
The best candidates have true volumetric hollowing in the tear trough, good skin quality and elasticity, and no significant malar edema, festoons, or fat pad herniation. Patients with excess skin laxity, prominent eye bags, fluid retention tendencies, or certain medical conditions are generally not ideal candidates and may benefit from alternative approaches. A detailed in-person assessment is the only way to determine suitability accurately.
Is under-eye filler reversible?
Yes. Hyaluronic acid fillers used in the tear trough area can be dissolved with an injection of hyaluronidase at any time. This reversibility is one of the key advantages of HA-based fillers compared to surgical options. It also means that if swelling, asymmetry, or the Tyndall effect develops, a corrective solution is available.
